Industries

MedTech

Fostering sustainable industry growth

From advancing technology and the impacts of value-based healthcare to diversified delivery points and increasingly personalized care, the MedTech industry is evolving—and creating the possibility for growth.

As your partner, we’ll work closely with you to uncover opportunities across the industry, accelerate innovation and deliver tomorrow’s standard of care.

Why choose Alira Health?

As your partner, we’ll work closely with you to uncover opportunities across the pharma industry, accelerate innovation, and deliver tomorrow’s standard of care. You’ll benefit from our:

  • 360° lifecycle approach

    that supports products, technologies, and services from concept ideation to creation and commercialization

  • Regulatory

    clinical, and health expertise in medical affairs strategy and execution

  • Management consulting

    to define growth initiatives and accelerate market penetration. Learn more

  • Global transaction advisory services

    including M&A, licensing, partnering and distribution, and capital raises. Learn more

  • In-depth experience

    across the entire healthcare ecosystem—suppliers, payers, providers, and patients

  • Fully collaborative team

    of bankers, scientists, strategists, and doctors who deliver a holistic view of each project

Areas of expertise

Alira Health teams bring together top talent from every life science and healthcare sector to take your innovation from strategy to reality. Our teams specialize in:
  • Cardiovascular
  • Companion diagnostics
  • Critical care
  • Diabetes
  • Drug and device combination
  • Drug delivery
  • Fluid management
  • Infection control
  • Interventional medicine
  • In vitro diagnostics
  • Medical imaging
  • Minimally invasive surgery
  • Neurovascular
  • Oncology
  • Orthopedics
  • Patient monitoring
  • Precision medicine
  • Robotics
  • Surgical equipment
  • Wearables
  • Wound care

Local insights, global reach

Since 1999, Alira Health has increased value for its pharma, biotech, and MedTech clients around the world. Our local presence and global collaboration combined with our deep domain experience allows us to deliver actionable insights.
20+
Years serving pharma and MedTech clients
50%
Of the top 50 pharma companies are advised by Alira Health
8
Global offices in Boston, San Francisco, Paris, Barcelona, Munich, Milan, Geneva, and Basel

Working together to transform healthcare

As your industry evolves, we’re ready to help you lead the way.

Contact us
David Uffer
David Uffer
Senior Partner, Vice President, MedTech
Our integrated approach sets us apart—we bring together experts from across the practice to deliver guidance from strategy to tactical execution.

Explore our related publications:

Market Access MedTech
Multimedia February 26, 2021
Pricing in MedTech: Disentangling the Roles of Payers, DRGs, and Procurement
Join host Kenny Carberry, Associate Director of Clinical Development, Dan Legg, former Director of Clinical Sourcing at Guy’s & St Thomas at the St Thomas Hospital in London and CEO(...)
MedTech Pharma
Publications February 8, 2021
Infographic: 2021 Trends in Healthcare
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.
MedTech Pharma
News February 4, 2021
2020 Year in Review
With 2021 in full swing, we want to take a moment to reflect on last year’s achievements and congratulate the entire Alira Health Team for their hard work and dedication to healthcare(...)
Market Access MedTech
Publications December 5, 2020
Critical Success Factors in Market Access
Today’s MedTech market is more concentrated than ever, with critical factors that need to be examined to advance a new product.
M&A MedTech
Publications October 10, 2020
Q3 2020 Medical Device Contract Development and Manufacturing M&A Report
Despite the COVID-19 pandemic, M&A activity in the global CDMO industry has been exceptionally strong in 2020 with a record number of transactions completed during the third quarter alone.
Market Access MedTech
News August 29, 2020
We Announce a New Collaboration with Mark Inigo Jones on Parallel Trade Management
We are pleased to announce a new collaboration with Mark Inigo Jones, an industry leader in European parallel trade of pharmaceutical products.
MedTech Regulatory
Publications August 11, 2020
CMS Issues Proposed Rule to Cover ‘Breakthrough’ Medical Devices
The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule this week that would give breakthrough medical devices national Medicare coverage on the same day they receive(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.